Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients
Gang Liu,* Qiaosheng Wu,* Yili Wang, Qiuyun Xiong, Feiguo Fu Department of Breast Surgery, The Third Hospital of Nanchang City, Key Laboratory of Breast Diseases, Nanchang, Jiangxi 330009, China *These authors contributed equally to this work Background: Deleted in breast cancer 1 (DBC1) is belie...
Main Authors: | Liu G, Wu Q, Wang Y, Xiong Q, Fu F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/deleted-in-breast-cancer-1-as-a-potential-prognostic-biomarker-in-huma-peer-reviewed-article-OTT |
Similar Items
-
OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts
by: Zhongyi Yan, et al.
Published: (2019-12-01) -
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients
by: Karen Zaguirre, et al.
Published: (2021-03-01) -
Prognostic factors influencing prognosis in early breast cancer patients
by: Safa Najafi, et al.
Published: (2019-06-01) -
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
by: Balázs Győrffy
Published: (2021-01-01) -
Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
by: Xiang Song, et al.
Published: (2019-09-01)